🇺🇸 FDA

Company profile · Sponsor

Bicara

Bicara Therapeutics

BCAX · NYSE pharma BOSTON, MA, USA
Pipeline
6
Drugs
0
Patents
0

Quick answer

Bicara (BCAX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker BCAX
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0002023658

Pipeline (6)

Search pipeline →

  1. Ficerafusp alfa

    Bicara

    Metastatic Head and Neck Squamous Cell Carcinoma

    phase 3 small molecule active

    1 trial

  2. KEYTRUDA 25 mg/mL concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, PEMBROLIZUMAB, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Saline bag, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Ficerafusp Alfa, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Ficerafusp A

    Bicara

    Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

    phase 3 small molecule active

    1 trial

  3. Ficerafusp alfa

    Bicara

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 2 small molecule active

    1 trial

  4. Ficerafusp alfa

    Bicara

    Squamous Cell Carcinoma of Head and Neck (SCCHN)

    phase 2 small molecule active

    1 trial

  5. Pembrolizumab

    Bicara

    Head and Neck Squamous Cell Carcinoma

    phase 2 mab active

    1 trial

  6. BCA101

    Bicara

    Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Bicara?

Bicara (BCAX) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Bicara sponsor?

We track 6 ClinicalTrials.gov-linked programs for Bicara, including Ficerafusp alfa and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Bicara company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.